Pharma-Bio Serv (PBSV) Amortizatization of Intangibles (2023 - 2026)

Pharma-Bio Serv (PBSV) has reported Amortizatization of Intangibles for 4 consecutive years, with $29388.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 28.99% year-over-year to $29388.0; the trailing twelve-month figure through Apr 2026 stood at $115259.0 (down 29.6% YoY), and the FY2025 full-year result was $169209.0, up 7.19% from the prior year.
• Amortizatization of Intangibles retreated to $29388.0 in Q1 2026 per PBSV's latest filing, from $43359.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $43359.0 in Q4 2025 and bottomed at $29388.0 in Q1 2026.
• Historically, Amortizatization of Intangibles has averaged $38668.1 across 4 years, with a median of $39170.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles gained 8.08% in 2025, then slipped 28.99% in 2026.
• Over 4 years, Amortizatization of Intangibles stood at $37553.0 in 2023, then grew by 8.08% to $40586.0 in 2024, then increased by 6.83% to $43359.0 in 2025, then plunged by 32.22% to $29388.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $29388.0, $43359.0, and $42512.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.